{"database": "lobbying", "table": "lobbying_activities", "rows": [[961694, "90782503-1dcf-4071-a247-9997dc55b452", "Q2", "THE DUBERSTEIN GROUP INC.", 12675, "AMERICA'S HEALTH INSURANCE PLANS", 2010, "second_quarter", "PHA", "*Antitrust exemption for pharmacies - HR 1204, Community Pharmacy Fairness Act of 2009.\n*Generic drugs - HR 1706, Protecting Consumer Access to Generic Drugs Act of 2009; HR 4899, Supplemental Appropriations Act, 2010; S 369, Preserve Access to Affordable Generics Act. *Generic biologics - HR 3590, Patient Protection and Affordable Care Act.\n\n*Federal Employee Health Benefit Program prescription drugs - HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act.\n\n*Prescription drug co-pays and formularies - S 1630, Affordable Access to Prescription Medications Act of 2009.", "HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of", 100000, null, 0, 0, "2010-07-19T12:12:35.030000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["961694"], "units": {}, "query_ms": 8.81559296976775, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}